Senior insider sale
President and CEO at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$761.6K
10.97K shares
What this filing means
AZAMIAN BOBAK R. plans to sell 10.97K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $761.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002440
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
10.97K
Shares to sell
$761.6K
Approx. market value
10.97K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/16/2026
10.97KTotal acquired10.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Restricted Stock Vesting Compensation | 10.97K | — |
| Total | 10.97K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.97K
Market value
$761.6K
3/17/2026
Total
Units
10.97K
Value
$761.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/17/2026 | 10.97K | $761.6K | NASDAQ | Planned |
| Total | 10.97K | $761.6K | ||